We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRS
3176
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$97K ﹤0.01%
+8,189
New +$146K
USX
3177
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$97K ﹤0.01%
+24,903
New +$112K
FBIO icon
3178
Fortress Biotech
FBIO
$113M
$95K ﹤0.01%
4,716
+3,906
+482% +$107K
AYLA
3179
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$95K ﹤0.01%
23,872
-25,394
-52% -$132K
SOLO
3180
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$94K ﹤0.01%
43,543
+5,606
+15% +$11.6K
SONX
3181
DELISTED
Sonendo, Inc.
SONX
$93K ﹤0.01%
22,948
-224,018
-91% -$1.24M
ADBE icon
3182
PUT
Adobe
ADBE
$99B
$92K ﹤0.01%
200
-2,000
-91% -$962K
FDX icon
3183
PUT
FedEx
FDX
$74B
$92K ﹤0.01%
400
-4,100
-91% -$963K
TUSK icon
3184
Mammoth Energy Services
TUSK
$125M
$91K ﹤0.01%
+42,495
New +$77.1K
GRCL
3185
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$89K ﹤0.01%
38,752
-48,576
-56% -$166K
BGDE
3186
Big Digital Energy Inc
BGDE
$27.7M
$87K ﹤0.01%
+142
New +$77.1K
OIIM
3187
DELISTED
02Micro International
OIIM
$87K ﹤0.01%
21,040
-3,507
-14% -$14.1K
HYPD
3188
Hyperion DeFi Inc
HYPD
$36.7M
$84K ﹤0.01%
346
-327
-49% -$81.2K
BKD icon
3189
Brookdale Senior Living
BKD
$3.67B
$83K ﹤0.01%
+11,795
New +$72K
XWEL icon
3190
XWELL
XWEL
$8.87M
$83K ﹤0.01%
3,682
-14,650
-80% -$392K
FPH icon
3191
Five Point Holdings
FPH
$395M
$82K ﹤0.01%
13,418
-81,956
-86% -$502K
AXDX
3192
DELISTED
Accelerate Diagnostics
AXDX
$81K ﹤0.01%
5,653
-3,209
-36% -$91.4K
ANIX icon
3193
Anixa Biosciences
ANIX
$120M
$80K ﹤0.01%
28,923
-13,050
-31% -$38.3K
ORGN
3194
DELISTED
Origin Materials
ORGN
$80K ﹤0.01%
403
+306
+315% +$53.4K
PVL
3195
Permianville Royalty Trust
PVL
$55.8M
$80K ﹤0.01%
+31,753
New +$76.5K
ANNX icon
3196
Annexon
ANNX
$814M
$77K ﹤0.01%
28,172
+21,912
+350% +$135K
BSIN
3197
Big Sky Industrial
BSIN
$58.1M
$77K ﹤0.01%
+17,746
New +$76.5K
JOB icon
3198
GEE Group
JOB
$23.1M
$76K ﹤0.01%
+138,205
New +$75.4K
AGMH icon
3199
AGM Group Holdings
AGMH
$1.82M
$72K ﹤0.01%
700
-362
-34% -$33.3K
MA icon
3200
PUT
Mastercard
MA
$497B
$72K ﹤0.01%
200
-14,600
-99% -$5.25M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.